Teladoc (NYSE:TDOC) New Coverage by Jefferies
In a research note revealed to investors and clients on 26 January, investment analysts at Jefferies began coverage on shares of Teladoc (NYSE:TDOC). The broker issued “Buy” rating on TDOC stock.
The initiation is well-received by stock traders, as NYSE:TDOC is currently trading 4.26% higher at $36.75 as of 8:07 AM New York time. Teladoc’s stock is 0% over the past 200 days. It has underperformed the S&P 500 Index, which has gained 6.00% over the same time.
Teladoc (NYSE:TDOC) Profile
Teladoc, Inc. is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Teladoc (NYSE:TDOC) traded up 4.26% on 26 January, hitting $36.75. A total of 1.43M shares of the company’s stock traded hands. This is up from average of 981,870 shares. Teladoc has a 52 week low of $15.65 and a 52 week high of $37.55. The company has a market cap of $2.09B and a P/E ratio of 0.
Get the latest Teladoc (NYSE:TDOC) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Jefferies Has Initiated Coverage On Teladoc (NYSE:TDOC) Stock With “Buy” Rating appeared first on Octafinance.